Crohn's disease (CD) is a chronic, progressive, and disabling inflammatory bowel disease (IBD) with an uncertain etiopathogenesis. CD can involve any site of the gastrointestinal tract from the mouth to the anus, and is associated with serious complications, such as bowel strictures, perforations, and fistula formation. The incidence and prevalence rates of CD in Korea are still lower compared with those in Western countries, but they have been rapidly increasing during the recent decades. Although there are no definitive curative modalities for CD, various medical and surgical therapies have been applied for the treatment of this disease. Concerning CD management, there have been substantial discrepancies among clinicians according to their personal experience and preference. To suggest recommendable approaches to the diverse problems of CD and to minimize the variations in treatment among physicians, guidelines for the management of CD were first published in 2012 by the IBD Study Group of the Korean Association for the Study of Intestinal Diseases. These are the revised guidelines based on updated evidence, accumulated since 2012. These guidelines were developed by using mainly adaptation methods, and encompass induction and maintenance treatment of CD, treatment based on disease location, treatment of CD complications, including stricture and fistula, surgical treatment, and prevention of postoperative recurrence. These are the second Korean guidelines for the management of CD and will be continuously revised as new evidence is collected.

Citations

Citations to this article as recorded by  

• Anti–Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women With Inflammatory Bowel Disease
  Yongtai Cho, Eun-Young Choi, Ahhyung Choi, Jung Yeol Han, Byong Duk Ye, Ju Hwan Kim, Ju-Young Shin
  American Journal of Gastroenterology.2025; 120(1): 241.     CrossRef
• Appraisal of current surgical guidelines for inflammatory bowel disease using the AGREE‐S instrument: A scoping review
  Zarnigar Mussarat Khan, Camille Ball, Dalha Saeed, Grace Tai, Shaneil Chandran, Abhishek Vashista, Simon Davey, Matthew James Lee, Steven R. Brown, Daniel Hind, Adele Elizabeth Sayers
  Colorectal Disease.2025;[Epub]     CrossRef
• Comparison of 1‐Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study
  Luan Minh Dang, Eun Soo Kim, Kyeong Ok Kim, Yoo Jin Lee, Hoang Huu Bui, Chuong Dinh Nguyen, Chi Thi Nguyen, Nam Hoai Nguyen, Hien Thi‐Thu Nguyen, Nga Thi Dinh, Lien Thi‐Phuong Nguyen, Khien Van Vu, Minh Cuong Duong
  JGH Open.2025;[Epub]     CrossRef
• Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn’s Disease: A Multicenter Observational Study
  Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee Cheon
  Digestive Diseases and Sciences.2024; 69(3): 901.     CrossRef
• Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
  Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
  Gut and Liver.2024; 18(2): 294.     CrossRef
• Mobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease
  Yoo Jin Lee, Sang Gyu Kwak, Eun Soo Kim, Sung Kook Kim, Hyun Seok Lee, Yun Jin Chung, Byung Ik Jang, Kyeong Ok Kim, Jeongseok Kim, Hyeong Ho Jo, Eun Young Kim
  Scientific Reports.2024;[Epub]     CrossRef
• Risks of Cancer Associated with Therapeutic Drugs for Inflammatory Bowel Disease
  Won Moon, Jae Jun Park
  The Korean Journal of Gastroenterology.2024; 83(6): 233.     CrossRef
• Modern treatment of perianal fistulas following Crohn’s disease
  A.L. Bejanyan, A.A. Bumbazhai, K.N. Petrenko, A.A. Sumbaev, A.V. Matinyan, I.I. Eremin
  Regenerative biotechnologies, preventive, digital and predictive medicine.2024; 1(2): 49.     CrossRef
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors
  Sang Un Kim, Hyun Seok Lee
  The Korean Journal of Gastroenterology.2024; 84(2): 35.     CrossRef
• Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
  Joo Kyung Kim, Jae Hee Cheon
  Journal of Yeungnam Medical Science.2023; 40(1): 37.     CrossRef
• Comparison of the Persistence of Anti-TNF Agents and Ustekinumab in Patients with Crohn’s Disease: A Study Based on the Korean National Database
  Gi Hyeon Seo, Sung Hoon Jung
  Journal of Clinical Medicine.2023; 12(6): 2397.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• Can balloon-assisted enteroscopy predict disease outcomes in patients with small-bowel Crohn’s disease?
  Ji Eun Na, Sung Noh Hong, Ji Eun Kim, Eun Ran Kim, Young-Ho Kim, Dong Kyung Chang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases
  Yong Eun Park, Hye Su Moon, Dongeun Yong, Hochan Seo, Jinho Yang, Tae-Seop Shin, Yoon-Keun Kim, Jin Ran Kim, Yoo Na Lee, Young-Ho Kim, Joo Sung Kim, Jae Hee Cheon
  Scientific Reports.2022;[Epub]     CrossRef
• Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
  Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
  Intestinal Research.2022; 20(4): 452.     CrossRef
• Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
  Seung Wook Hong, Byong Duk Ye, Jae Hee Cheon, Ji Hyun Lee, Ja Seol Koo, Byung Ik Jang, Kang-Moon Lee, You Sun Kim, Tae Oh Kim, Jong Pil Im, Geun Am Song, Sung-Ae Jung, Hyun Soo Kim, Dong Il Park, Hyun-Soo Kim, Kyu Chan Huh, Young-Ho Kim, Jae Myung Cha, Ge
  Gut and Liver.2022; 16(6): 907.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
  Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park
  Intestinal Research.2021; 19(1): 62.     CrossRef
• Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn’s Disease Patients
  Pyeong Hwa Kim, Seo Hee Kim, Young Ah Cho, Hee Mang Yoon, Jin Seong Lee, Ah Young Jung, Seak Hee Oh, Dae Yeon Kim, Jung-Man Namgoong, Kyung Mo Kim
  Journal of Crohn's and Colitis.2021; 15(7): 1152.     CrossRef
• Predictors of reoperation for perianal fistula in Crohn's disease
  Kwangwoo Nam, Won Beom Jung, Seung Bum Lee, Jae Seung Soh, Song Soo Yang, Seok Won Jung
  Journal of Digestive Diseases.2021; 22(6): 334.     CrossRef
• Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
  Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
  Intestinal Research.2020; 18(1): 85.     CrossRef
• Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
• Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease
  Min Seob Kwak, Jae Myung Cha, Ji Hyun Ahn, Min Kyu Chae, Sara Jeong, Hun Hee Lee
  Medicine.2020; 99(10): e18925.     CrossRef
• Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
  Youn I Choi, Yoon Jae Kim, Jun-Won Chung, Kyoung Oh Kim, Hakki Kim, Rae Woong Park, Dong Kyun Park
  JMIR Medical Informatics.2020; 8(4): e15124.     CrossRef
• Pregnancy outcomes in women with inflammatory bowel disease: a 10‐year nationwide population‐based cohort study
  Han H. Lee, Jung Min Bae, Bo‐In Lee, Kang‐Moon Lee, Jeong H. Wie, Jin S. Kim, Young‐Seok Cho, Sung‐Ae Jung, Sang W. Kim, Hwang Choi, Myung‐Gyu Choi
  Alimentary Pharmacology & Therapeutics.2020; 51(9): 861.     CrossRef
• Effects of various genetic polymorphisms on thiopurine treatment‐associated outcomes for Korean patients with Crohn's disease
  Rihwa Choi, Mi‐Na Lee, Kyunga Kim, Sun‐Young Baek, Tae Jun Kim, Sung Noh Hong, Young‐Ho Kim, Soo‐Youn Lee
  British Journal of Clinical Pharmacology.2020; 86(11): 2302.     CrossRef
• Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
  Jae Jun Park
  Journal of Rheumatic Diseases.2020; 27(3): 128.     CrossRef
• Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
  Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
  Digestive Diseases.2020; 38(6): 507.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
  Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
  Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
• Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease
  Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim
  International Journal of Colorectal Disease.2019; 34(10): 1713.     CrossRef
• Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics
  Ji Young Chang, Jae Hee Cheon
  Digestive Diseases and Sciences.2019; 64(9): 2395.     CrossRef
• Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
  Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
  Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
• Can Umbilical Cord Mesenchymal Stem Cells Treatment Be a Hope for Patients with Refractory Crohn's Disease?
  Younjoo Kim
  Gut and Liver.2018; 12(1): 5.     CrossRef
• Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation
  Seong Ran Jeon, Jocelyn Chai, Christiana Kim, Christine H. Lee
  Current Infectious Disease Reports.2018;[Epub]     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
• Novel treatments for inflammatory bowel disease
  Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
  The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
• Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population‐based cohort study
  J. M. Bae, H. H. Lee, B.‐I. Lee, K.‐M. Lee, S. H. Eun, M.‐L. Cho, J. S. Kim, J. M. Park, Y.‐S. Cho, I. S. Lee, S. W. Kim, H. Choi, M.‐G. Choi
  Alimentary Pharmacology & Therapeutics.2018; 48(2): 196.     CrossRef
• Monitoring Disease Activity: How and When?
  Kang-Moon Lee
  The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
• Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats
  Sehyung Pak, Sung Wook Hwang, In Kyong Shim, Sang Mun Bae, Yeon- Mi Ryu, Han-Byul Kim, Eun-ju Do, Hye-Nam Son, Eun-ji Choi, Sun-ha Park, Sang-Yeob Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Nobuo Kanai, Masanori Maeda, Teruo Okano, Dong-Hoon Yang
  Scientific Reports.2018;[Epub]     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
  Ji Min Lee, Yoon Jae Kim, Kang-Moon Lee, Hyuk Yoon, Bo-In Lee, Dae Bum Kim, Donghoon Kang
  Scandinavian Journal of Gastroenterology.2018; 53(10-11): 1280.     CrossRef
• Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
  Jong Pil Im
  Intestinal Research.2017; 15(2): 147.     CrossRef
• Real-world Experience of Anti–tumor Necrosis Factor Therapy for Internal Fistulas in Crohnʼs Disease
  Taku Kobayashi, Asahi Hishida, Hiroki Tanaka, Yoichiro Nuki, Shigeki Bamba, Akihiro Yamada, Toshimitsu Fujii, Shinichiro Shinzaki, Yoko Yokoyama, Atsushi Yoshida, Keiji Ozeki, Shinya Ashizuka, Noriko Kamata, Sohachi Nanjo, Kazuki Kakimoto, Misaki Nakamura
  Inflammatory Bowel Diseases.2017; 23(12): 2245.     CrossRef
• Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
  Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
  Intestinal Research.2017; 15(4): 524.     CrossRef
• Short-Term Outcome of Infliximab Therapy in Pediatric Crohn's Disease: A Single-Center Experience
  Dai Jung, Sunghee Lee, Insook Jeong, Seak Hee Oh, Kyung Mo Kim
  Pediatric Gastroenterology, Hepatology & Nutrition.2017; 20(4): 236.     CrossRef

Citations

Citations to this article as recorded by  

• Modern treatment of perianal fistulas following Crohn’s disease
  A.L. Bejanyan, A.A. Bumbazhai, K.N. Petrenko, A.A. Sumbaev, A.V. Matinyan, I.I. Eremin
  Regenerative biotechnologies, preventive, digital and predictive medicine.2024; 1(2): 49.     CrossRef
• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
• Clinical Characteristics of Korean Patients with Elderly-Onset Crohn’s Disease: Results from the Prospective CONNECT Study
  You Sun Kim, Min Jeong Na, Byong Duk Ye, Jae Hee Cheon, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2022; 16(6): 995.     CrossRef
• Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
  Seung Wook Hong, Byong Duk Ye, Jae Hee Cheon, Ji Hyun Lee, Ja Seol Koo, Byung Ik Jang, Kang-Moon Lee, You Sun Kim, Tae Oh Kim, Jong Pil Im, Geun Am Song, Sung-Ae Jung, Hyun Soo Kim, Dong Il Park, Hyun-Soo Kim, Kyu Chan Huh, Young-Ho Kim, Jae Myung Cha, Ge
  Gut and Liver.2022; 16(6): 907.     CrossRef
• Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
  Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu
  Annals of Coloproctology.2021; 37(1): 5.     CrossRef
• Epidemiology and diagnosis of inflammatory bowel diseases
  Kang-Moon Lee
  Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
• Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn’s Disease: Results from the CONNECT Study
  Seok-Hoo Jeong, Ja Sung Choi, Jin Woo Kim, Hee Man Kim, Hyun-Soo Kim, Jong Pil Im, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Won Ho Kim, Byong Duk Ye, Young-Ho Kim, Dong Soo Han
  Journal of Clinical Medicine.2020; 10(1): 116.     CrossRef
• Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
  Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Hom
  Intestinal Research.2019; 17(3): 330.     CrossRef
• Postoperative course of Crohn disease according to timing of bowel resection
  Ji Min Lee, Kang-Moon Lee, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, Dong Soo Han, Chang Kyun Lee, Hyun-Ju Park
  Medicine.2018; 97(16): e0459.     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef
• Second Korean Guidelines for the Management of Crohn's Disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
• Second Korean guidelines for the management of Crohn's disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  Intestinal Research.2017; 15(1): 38.     CrossRef
• Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn’s Disease
  Su Hwan Kim, Seung Hyeon Jang, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, You Sun Kim, Dong Soo Han, Joo Sung Kim
  The American Journal of the Medical Sciences.2017; 353(5): 439.     CrossRef
• A coding variant inFTOconfers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD
  Han Sang Kim, Jae Hee Cheon, Eun Suk Jung, Joonhee Park, Sowon Aum, Soo Jung Park, Sungho Eun, Jinu Lee, Ulrich Rüther, Giles S H Yeo, Marcella Ma, Kyong Soo Park, Takeo Naito, Yoichi Kakuta, Ji Hyun Lee, Won Ho Kim, Min Goo Lee
  Gut.2017; 66(11): 1926.     CrossRef
• Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
  Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon, Won Ho Kim
  Inflammatory Bowel Diseases.2017; 23(7): 1071.     CrossRef
• Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study
  Sung Wook Hwang, Jee Hyun Kim, Jong Pil Im, Byong Duk Ye, Hoon Sup Koo, Kyu Chan Huh, Jae Hee Cheon, You Sun Kim, Young Ho Kim, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Journal of Gastroenterology and Hepatology.2017; 32(10): 1716.     CrossRef
• Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study
  Bun Kim, Jae Hee Cheon, Hyun Jin Moon, Yi Rang Park, Byong Duk Ye, Suk‐Kyun Yang, Geom Seog Seo, Byung Ik Jang, You Sun Kim, Joo Sung Kim, Dong Soo Han, Young‐Ho Kim, Won Ho Kim
  Journal of Gastroenterology and Hepatology.2016; 31(1): 126.     CrossRef
• Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants
  Sung Noh Hong, Changho Park, Soo Jung Park, Chang Kyun Lee, Byong Duk Ye, You Sun Kim, Seungbok Lee, Jeesoo Chae, Jong-Il Kim, Young-Ho Kim
  Gut.2016; 65(5): 788.     CrossRef
• Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
  Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2016; 10(4): 595.     CrossRef
• The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study
  Young Seok Doh, You Sun Kim, Song I Bae, Jong Pil Im, Jae Hee Cheon, Byong Duk Ye, Ji Won Kim, Young Sook Park, Ji Hyun Lee, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
  BMC Gastroenterology.2015;[Epub]     CrossRef
• Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study
  Chang Mo Moon, Sung-Ae Jung, Seong-Eun Kim, Hyun Joo Song, Yunho Jung, Byong Duk Ye, Jae Hee Cheon, You Sun Kim, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Mathias Chamaillard
  PLOS ONE.2015; 10(12): e0144390.     CrossRef
• Long-term Clinical Outcomes of Urban Versus Rural Environment in Korean Patients with Crohn's Disease: Results from the CONNECT Study
  Y. S. Jung, D. I. Park, B. D. Ye, J. H. Cheon, Y. S. Kim, Y. H. Kim, J. S. Kim, H. S. Chae, G. H. Baik, D. S. Han
  Journal of Crohn's and Colitis.2015; 9(3): 246.     CrossRef
• Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
  Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
  Intestinal Research.2015; 13(3): 213.     CrossRef
• Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study
  Sinyoung Park, Yang Hee Noh, Sun Young Rha, Won Ho Kim, Jae Hee Cheon
  Intestinal Research.2015; 13(3): 274.     CrossRef
• Crohn's disease in Korea: past, present, and future
  Kang-Moon Lee, Ji Min Lee
  The Korean Journal of Internal Medicine.2014; 29(5): 558.     CrossRef

Citations

Citations to this article as recorded by  

• Postoperative course of Crohn disease according to timing of bowel resection
  Ji Min Lee, Kang-Moon Lee, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, Dong Soo Han, Chang Kyun Lee, Hyun-Ju Park
  Medicine.2018; 97(16): e0459.     CrossRef
• Second Korean Guidelines for the Management of Crohn's Disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
• Second Korean guidelines for the management of Crohn's disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  Intestinal Research.2017; 15(1): 38.     CrossRef
• Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
  Young Sun Kim, Sung-Ae Jung, Kang-Moon Lee, Soo Jung Park, Tae Oh Kim, Chang Hwan Choi, Hyun Gun Kim, Won Moon, Chang Mo Moon, Hye Kyoung Song, Soo-Young Na, Suk-Kyun Yang
  Intestinal Research.2017; 15(3): 338.     CrossRef
• Computed Tomography Enterography and Magnetic Resonance Enterography in the Diagnosis of Crohn's Disease
  Se Hyung Kim
  Intestinal Research.2015; 13(1): 27.     CrossRef
• Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea
  Jae Hee Cheon, You Sun Kim, Byong Duk Ye, Kang Moon Lee, Young Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
  Intestinal Research.2014; 12(3): 173.     CrossRef
• Crohn's disease in Korea: past, present, and future
  Kang-Moon Lee, Ji Min Lee
  The Korean Journal of Internal Medicine.2014; 29(5): 558.     CrossRef
• Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine
  Chang Kyun Lee, Hyun-Soo Kim, Byong Duk Ye, Kang-Moon Lee, You Sun Kim, Sang Youl Rhee, Hyo-Jong Kim, Suk-Kyun Yang, Won Moon, Ja-Seol Koo, Suck-Ho Lee, Geom Seog Seo, Soo Jung Park, Chang Hwan Choi, Sung-Ae Jung, Sung Noh Hong, Jong Pil Im, Eun Soo Kim
  Journal of Crohn's and Colitis.2014; 8(5): 384.     CrossRef
• Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
  Seong Yeon Jeong, Jeong Seop Moon, Kyu Joo Park, You Sun Kim
  Intestinal Research.2014; 12(1): 74.     CrossRef
• Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
  Nam Hee Kim, Yoon Suk Jung, Chang Mo Moon, Shin Yeong Lee, Eun Ran Kim, Young Ho Kim, Chang Kyun Lee, Suck Ho Lee, Jae Hak Kim, Kyu Chan Huh, Soon Man Yoon, Hyun Joo Song, Sun-Jin Boo, Hyun Joo Jang, You Sun Kim, Kang-Moon Lee, Jeong Eun Shin, Dong Il Par
  Intestinal Research.2014; 12(4): 281.     CrossRef
• Clinical Outcome of Treatment with Infliximab in Crohn's Disease: A Single-Center Experience
  Yeon-Ju Kim, Jung-Wook Kim, Chang Kyun Lee, Hyun Jin Park, Jae-Jun Shim, Jae Young Jang, Suk Ho Dong, Hyo Jong Kim, Byung-Ho Kim, Young Woon Chang
  The Korean Journal of Gastroenterology.2013; 61(5): 270.     CrossRef

Citations

Citations to this article as recorded by  

• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines
  Soo-Young Na
  The Korean Journal of Medicine.2023; 98(5): 223.     CrossRef
• Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
  Young Sun Kim, Sung-Ae Jung, Kang-Moon Lee, Soo Jung Park, Tae Oh Kim, Chang Hwan Choi, Hyun Gun Kim, Won Moon, Chang Mo Moon, Hye Kyoung Song, Soo-Young Na, Suk-Kyun Yang
  Intestinal Research.2017; 15(3): 338.     CrossRef
• Synergic modulation of the inflammatory state of macrophages utilizing anti-oxidant and phosphatidylserine-containing polymer–lipid hybrid nanoparticles
  Md. Zahangir Hosain, Kazuki Yuzuriha, Khadijah Khadijah, Masafumi Takeo, Akihiro Kishimura, Yoshihiko Murakami, Takeshi Mori, Yoshiki Katayama
  MedChemComm.2017; 8(7): 1514.     CrossRef
• Second Korean Guideline for the Management of Ulcerative Colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
• Second Korean guidelines for the management of ulcerative colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  Intestinal Research.2017; 15(1): 7.     CrossRef
• Increased Risk of Asymptomatic Gallstones in Patients With Ulcerative Colitis
  Jung Hoon Ha, Young Sook Park, Choon Sik Seon, Byung Kwan Son, Sang Bong Ahn, Young Kwan Jo, Seong Hwan Kim, Yun Ju Jo, Jung Hwan Kim, Jee Hye Han, Yoon Young Jung, Sook Hee Chung
  Intestinal Research.2015; 13(2): 122.     CrossRef
• Pharmacologic treatment for inflammatory bowel disease
  Kwang Jae Lee
  Journal of the Korean Medical Association.2015; 58(1): 57.     CrossRef
• Author's Reply
  Jaeyoung Chun, Jong Pil Im
  Intestinal Research.2015; 13(2): 184.     CrossRef
• Current and Emerging Biologics for Ulcerative Colitis
  Sung Chul Park, Yoon Tae Jeen
  Gut and Liver.2015; 9(1): 18.     CrossRef
• Colon Cancer Screening and Surveillance in Inflammatory Bowel Disease
  Song I Bae, You Sun Kim
  Clinical Endoscopy.2014; 47(6): 509.     CrossRef
• A Case of Ulcerative Colitis Patient with Colonic Stenosis and Enterocutaneous Fistula
  Seong Yeon Jeong, You Sun Kim, Kyeong Sam Ok, Sun Ok Kwon, Jin Nam Kim, Jeong Seop Moon, Yun Kyung Kang, Seong Woo Hong
  Intestinal Research.2012; 10(4): 388.     CrossRef